Mar. 19 at 9:22 PM
$ABUS HELLO??????
Lindsay Androski, JD, MBA, CFA
President & CEO and Chairperson
Ms. Androski joined Arbutus in February 2025 as President and CEO and Chairperson of the Board. Ms. Androski, an MIT-trained biologist, has nearly 30 years of experience in biotechnology, law, and academia. She also currently serves as Special Counsel at Genevant Sciences and has previously served in a variety of roles at Roivant, including President and CEO of Roivant Social Ventures and Vice President, Head of Acquisitions. At Roivant she built and led the team responsible for the in-licensing or acquisition of more than 30 therapeutic programs, resulting in the launch and incubation of 16 subsidiary biotechs and several successful IPOs. Prior to joining Roivant, Ms. Androski spent more than a decade as a trial lawyer, including as an Assistant U.S. Attorney in the Eastern District of Virginia. Ms. Androski holds two Bachelor of Science degrees from the Massachusetts Institute of Technology, JD and MBA
